Brainstorm Cell Therapeutics (BCLI) Announces Receipt of $3.1M from Exercise of Warrants
Brainstorm Cell Therapeutics (NASDAQ: BCLI) announced that since January 2, 2015 it has received approximately $3.1 million from the exercise of …
Go to Source